Zhou F[au] - Search Results

Year	Number of Results
1979	1
1980	1
1981	3
1982	3
1983	7
1984	3
1985	7
1986	4
1987	10
1988	12
1989	12
1990	14
1991	20
1992	16
1993	15
1994	18
1995	28
1996	25
1997	19
1998	24
1999	24
2000	23
2001	45
2002	56
2003	44
2004	84
2005	90
2006	122
2007	133
2008	180
2009	206
2010	213
2011	306
2012	345
2013	445
2014	439
2015	498
2016	560
2017	615
2018	708
2019	770
2020	896
2021	1067
2022	904
2023	1

1

Maternal inheritance of glucose intolerance via oocyte TET3 insufficiency.

Chen B, Du YR, Zhu H, Sun ML, Wang C, Cheng Y, Pang H, Ding G, Gao J, Tan Y, Tong X, Lv P, Zhou F, Zhan Q, Xu ZM, Wang L, Luo D, Ye Y, Jin L, Zhang S, Zhu Y, Lin X, Wu Y, Jin L, Zhou Y, Yan C, Sheng J, Flatt PR, Xu GL, Huang H. Chen B, et al. Among authors: zhou f. Nature. 2022 May;605(7911):761-766. doi: 10.1038/s41586-022-04756-4. Epub 2022 May 18. Nature. 2022. PMID: 35585240

2

Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy.

Long H, Jia Q, Wang L, Fang W, Wang Z, Jiang T, Zhou F, Jin Z, Huang J, Zhou L, Hu C, Wang X, Zhang J, Ba Y, Gong Y, Zeng X, Zeng D, Su X, Alexander PB, Wang L, Wang L, Wan YY, Wang XF, Zhang L, Li QJ, Zhu B. Long H, et al. Among authors: zhou f. Cancer Cell. 2022 Jun 13;40(6):674-693.e7. doi: 10.1016/j.ccell.2022.04.018. Epub 2022 May 19. Cancer Cell. 2022. PMID: 35594863

3

SARS-CoV-2 Omicron variant: recent progress and future perspectives.

Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. Fan Y, et al. Among authors: zhou f. Signal Transduct Target Ther. 2022 Apr 28;7(1):141. doi: 10.1038/s41392-022-00997-x. Signal Transduct Target Ther. 2022. PMID: 35484110 Free PMC article. Review.

4

Structural basis for the tethered peptide activation of adhesion GPCRs.

Ping YQ, Xiao P, Yang F, Zhao RJ, Guo SC, Yan X, Wu X, Zhang C, Lu Y, Zhao F, Zhou F, Xi YT, Yin W, Liu FZ, He DF, Zhang DL, Zhu ZL, Jiang Y, Du L, Feng SQ, Schöneberg T, Liebscher I, Xu HE, Sun JP. Ping YQ, et al. Among authors: zhou f. Nature. 2022 Apr;604(7907):763-770. doi: 10.1038/s41586-022-04619-y. Epub 2022 Apr 13. Nature. 2022. PMID: 35418678

5

Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial.

Bao J, Huang Y, Li X, Yang A, Zhou F, Wu J, Wang C, Li Y, Lim EW, Spiegel DP, Drobe B, Chen H. Bao J, et al. Among authors: zhou f. JAMA Ophthalmol. 2022 May 1;140(5):472-478. doi: 10.1001/jamaophthalmol.2022.0401. JAMA Ophthalmol. 2022. PMID: 35357402 Free PMC article. Clinical Trial.

6

Retraction Notice to: H3K27 demethylase KDM6B aggravates ischemic brain injury through demethylation of IRF4 and Notch2-dependent SOX9 activation.

Chang L, An Z, Zhang J, Zhou F, Wang D, Liu J, Zhang Y. Chang L, et al. Among authors: zhou f. Mol Ther Nucleic Acids. 2022 May 4;28:533. doi: 10.1016/j.omtn.2022.04.022. eCollection 2022 Jun 14. Mol Ther Nucleic Acids. 2022. PMID: 35592493 Free PMC article.

7

Retraction Note to: LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1.

Chang L, Wang J, Zhou F, Wang D, Chen R, Zhang Y, Zhang J. Chang L, et al. Among authors: zhou f. J Neurooncol. 2022 May;157(3):593. doi: 10.1007/s11060-022-04023-6. J Neurooncol. 2022. PMID: 35482176 No abstract available.

8

[Retracted] MicroRNA‑379 acts as a tumor suppressor in non‑small cell lung cancer by targeting the IGF‑1R‑mediated AKT and ERK pathways.

Zhou F, Nie L, Feng D, Guo S, Luo R. Zhou F, et al. Oncol Rep. 2022 Jul;48(1):128. doi: 10.3892/or.2022.8339. Epub 2022 Jun 1. Oncol Rep. 2022. PMID: 35642683 Free PMC article.

9

[Retracted] MicroRNA-199b targets the regulation of ZEB1 expression to inhibit cell proliferation, migration and invasion in non‑small cell lung cancer.

Wang J, Zhou F, Yin L, Zhao L, Zhang Y, Wang J. Wang J, et al. Among authors: zhou f. Mol Med Rep. 2022 Oct;26(4):316. doi: 10.3892/mmr.2022.12832. Epub 2022 Aug 25. Mol Med Rep. 2022. PMID: 36004473 Free PMC article.

10

Association Between Neddylation and Immune Response.

Zhu J, Chu F, Zhang M, Sun W, Zhou F. Zhu J, et al. Among authors: zhou f. Front Cell Dev Biol. 2022 May 5;10:890121. doi: 10.3389/fcell.2022.890121. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35602593 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results